NCT05879939

Brief Summary

The goal of this observational study is to characterize the standardized stimulation parameter for noninvasive, transcutaneous, repetitive phrenic nerve electrical stimulation. The main questions it aims to answer are:

  • Is the phrenic nerve repetitive electrical stimulation test feasible for use as non-invasive transcutaneous electrical stimulation?
  • What is the most optimal stimulation parameters for repetitive phrenic nerve electrical stimulation in healthy adult populations in terms of effective and safe activation of diaphragm?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

April 17, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 30, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2023

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

March 23, 2023

Last Update Submit

March 9, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Phrenic nerve compound muscle action potential (CMAP) amplitude (mV)

    ∙ CMAP Amplitude (mV)

    Baseline

  • ∙ Phrenic nerve compound muscle action potential (CMAP) duration (ms)

    ∙ CMAP duration (ms)

    Baseline

  • ∙ Phrenic nerve compound muscle action potential (CMAP) area (mV∙ms)

    ∙ CMAP area (mV∙ms)

    Baseline

Secondary Outcomes (4)

  • Respiratory function

    Baseline

  • Diaphragmatic function

    Baseline

  • Diaphragmatic function

    Baseline

  • Pain during phrenic stimulation

    Baseline

Interventions

Phrenic nerve electrical stimulation with different stimulation intensity and frequency

Eligibility Criteria

Age19 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Healthy adult population who have read the recruitment announcement, voluntarily expressed their intention to participate, and have met the eligibility criteria.

You may qualify if:

  • Koreans who speak Korean as their mother tongue, aged 19 or older and younger than 40.
  • Those who understood the purpose and procedure of this study and voluntarily participated with consent.

You may not qualify if:

  • \- Those who have any neuromuscular disease.
  • \- Those whom abnormal findings are observed on a neurological examination. e.g.) Cases with abnormal findings in peripheral motor nerve (median nerve) and sensory nerve (sural nerve) conduction studies performed in screening.
  • e.g.) People who have been diagnosed with a neuromuscular junctional diseases such as myasthenia gravis or receiving related treatment.
  • In the case of implantable electronic medical devices such as pacemakers, implantable cardioverter defibrillators (ICDs), and spinal cord stimulation devices.
  • Those who have any history of radiation therapy or chemotherapy for cancer within a year.
  • People who have a history of cardiovascular or cerebrovascular disease or lung disease within 6 months.
  • Those who have been diagnosed with a psychiatric/neurological problem or taking related medications that may affect electrophysiological study.
  • Those who are pregnant or may be pregnant.
  • Those who are judged to lack the cognitive ability to understand the explanation of the purpose and procedure of this study.
  • Those whom the researchers judge for other reasons to be inappropriate to participate in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

Study Officials

  • Sung Eun Hyun, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor (MD, PhD)

Study Record Dates

First Submitted

March 23, 2023

First Posted

May 30, 2023

Study Start

April 17, 2023

Primary Completion

July 18, 2023

Study Completion

July 18, 2023

Last Updated

March 12, 2024

Record last verified: 2024-03

Locations